# GLYCOPYRROLATE
> **ANDA212591** · Abbreviated New Drug Application (Generic) · Sponsor: NIVAGEN PHARMS INC · Approved 2021-10-13
## Drug
- **FDA Application Number:** ANDA212591
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** GLYCOPYRROLATE
- **Generic name:** GLYCOPYRROLATE
- **Active ingredients:** GLYCOPYRROLATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** NIVAGEN PHARMS INC
- **Manufacturer:** Nivagen Pharmaceuticals, Inc.
- **First approval:** 2021-10-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212591)
---
*MORVS · CC0 1.0*